ARCHIVE
ANNUAL REPORT
July 1, 2003 – June 30,
2004
SACKLER INSTITUTE FOR
DEVELOPMENTAL PSYCHOBIOLOGY
AT COLUMBIA UNIVERSITY
| |
Part I
Introduction
Highlights
Part II
Research Programs
- Basic Science Division
- Behavioral Neuroscience Division
- Clinical Research Division
- Developmental Neuroimaging
Laboratories
- Sackler Awardee
Part III
Financial Report
Appendix
Brochure on new MRI Research
Scanner |
| |
|
This report covers the third year of operation
of the Sackler Institute, established at Columbia April
27 th 2001 with a gift from the Sackler Foundation made
in December 2000. The Institute is an organization within
the College of Physicians and Surgeons and the Department
of Psychiatry that brings together federally funded
scientists active in research on the developmental origins
of vulnerability to psychiatric illness. Our faculty
brought in more than 6 million dollars in outside support
last year. The income from the endowment supports a
professorship for the Director of the Institute, and
has made a major contribution to the construction of
the new Sackler Laboratories at the New York State Psychiatric
Institute. In addition, it provides support for new
directions in faculty research and funds the annual
Sackler Award, a stipend for a postdoctoral fellow/junior
faculty worker to facilitate their transition to becoming
an independent researcher. Together with an annual contribution
to the Director's Fund by Columbia University, the Institute
sponsors conferences and symposia at National and International
meetings, makes ‘mini-grants' to selected Sackler Fellows
for their research costs, gives ' small seed money '
grants for novel research pilot studies that enable
subsequent grant applications for federal support, and
provides administrative support for the Institute.
The administrative structure and faculty
of the institute over the past year were as follows:
Director, Dr. Myron A. Hofer
Assistant Director, Dr. William P. Fifer
Administrative Assistant, Jennifer Knowles
Chief, Basic Science Division - Dr.
Thomas Jessell
Chiefs, Behavioral Neuroscience Division
- Drs. Michael Myers and William Fifer
Chief, Clinical Division - Dr. Myrna
Weissman
Head, Developmental Neuroimaging Laboratory
- Dr. Bradley Peterson
Liason, Cornell - Sackler Institute
- Dr. Jonathan Polan
Sackler Awardee: 2003 Dr. Cheryl Corcoran
Sackler Awardees: 2004 Dr. Mark Ansorge
and Dr. Jonathan Polan
The research programs of the faculty
and the 2003 Sackler Awardee are described in the second
section of this report along with their publications
for the year and their current Federal and other grant
support.
Part I - Highlights
Opening of the new Brain Imaging Laboratory
in the New York State Psychiatric Institute under the
direction of Bradley Peterson, took place in May of
2004. This suite of rooms centers around a powerful
'3 Tesla' scanner, and state-of-the art computer acquisition
and analysis equipment dedicated to use for research.
An extensive consultation and teaching program is available
for prospective users. (please see attachment). Studies
underway are described in the Research Program summaries
in Part II.
The Sackler Award competition in the
spring of 2004 elicited a record number of 9 applications.
Because there were so many good applications, and because
of an additional $50,000 gift from the Sackler Foundation
in February '04, we were able to make 2 awards. One
was to Dr. Mark Ansorge, a postdoctoral fellow with
Dr. Jay Gingrich in the Sackler Laboratories. His project
is titled "Early Life Inhibition of the Serotonin Transporter
Alters Emotional Behavior in Adult Mice". He has created
an animal model for understanding the vulnerability
to depression known to be due to a human genetic polymorphism
affecting the serotonin transporter gene that has been
mimicked in Dr. Gingrich's lab by a serotonin transporter
gene knockout in mice. This knockout effect is unlikely
to be due to altered expression in adulthood since inhibition
of serotonin transporter in adults by drugs such as
Prozac relieves depression in man and mouse. Mark has
found that Prozac given to mice during their neonatal
and weaning periods reproduces the effect of the gene
knockout, increasing depression-like behaviors. This
provides, for the first time, direct evidence for an
important (and paradoxical) early developmental role
for the serotonin transporter and may also help explain
the unexpected ill effects of SSRI antidepressant drugs
in childhood and adolescence. Planned research includes
search for a sensitive period, the central site and
the cellular/molecular mechanisms for the effect.
The second Sackler Award was a special
award to Dr. Jonathan Polan, the joint Cornell-Columbia
Sackler faculty member, for his studies titled: "Developmental
Dopaminergic Excess, Developmental Stress and Pathogenesis
of Schizophrenia". Dr. Polan has embarked on a faculty
mid-career training fellowship in the laboratory of
Eric Kandel. Here he is leaving the concepts and techniques
of molecular neurobiology in order to complement his
expertise in animal models of early behavior development
and apply them both to his future research in Developmental
Psychobiology.
Sackler faculty who received honors
and awards . Dr Fifer's seminal paper, demonstrating
for the first time that newborn infants can recognize
their own mother's voice, was designated as one of the
5 most important studies in child psychology published
since 1950, by the Society for Child Research on Development.
Dr. Hofer was appointed to the NIMH Council workgroup
on Priority Setting for the Basic Sciences of Mental
Health.
At the annual meeting of the American
Psychiatric Association in May 2004 an invited review
of Developmental Psychobiology was presented in a half
day session that drew an audience of several hundred.
Sackler faculty were well represented in this summary
of recent progress in the field. B.J. Casey (Chair)
and Bruce McCandliss represented the Cornell Sackler
and Myron Hofer, representing the Columbia Sackler,
gave a paper on the Developmental Psychobiology of Early
Attachment. A book titled "Developmental Psychobiology"
was published in May 2004 by American Psychiatric Publishing
Inc. based on the proceedings of the conference.
A joint meeting of members of the Cornell
and Columbia Sackler Institute Faculty was held in the
Fall of 2003 together with members of the Department
of Developmental Psychobiology, in the first of what
we plan to be an annual series. A number of short talks
were given with time for discussion around the talks
and at lunch. Another is planned for November 11, 2004.
We have found this is an effective way to spark collaborative
projects like the highly productive shared post doctoral
research project carried out a year ago by Inge-Marie
Eigsti on the attentional deficit in early autism. On
the basis of this work, Dr. Eigsti was able to secure
a tenure track position at the University of Connecticut
, where she moved in July 2004. In the spring of 2005
a joint meeting with faculty of the new Glasgow and
Edinburgh Institutes is planned with much
curiosity and anticipation on both sides
of the Atlantic .
On May 19 and 20, 2004 Dr. Michael Meaney,
a member of our outside Scientific Review Committee,
visited our laboratories and met with faculty members
and other developmental researchers working in his area
of research. Dr. Meaney also gave an informal presentation
describing his most recent research on molecular-genetic
and methylation-based mechanisms for the shaping of
hypothalmic-adrenocortical and anxiety behavior development
by variations in specific maternal behavior patterns.
This visit generated considerable interest among clinical
researchers such as Drs. Weissman and Peterson as well
as among the more basic behavioral neuroscientists.
These visits are also designed to give us the benefit
of outside review of the functioning of the Institute.
We sponsored Sackler Symposia at 2 international
conferences: one on Childhood Bipolar Disorder at the
Annual Meeting of the International Society for Developmental
Psychobiology in November 2003 in New Orleans . There
were presentations on the diagnosis, genetics, brain
imaging findings and effects of early trauma with an
excellent discussion by Susan Sweto of the NIMH. The
other was a symposium on Postnatal Neurogenesis at the
Winter Conference for Research on Early Development
in January of 2004. This was chaired by Dr. Elizabeth
Gould and presented the latest findings on how stress
and deprivation affect the differentiation of new neurons
in several brain regions during a time frame extending
into adulthood.
Small-grants of $1,000 to $5,000 were
awarded to purchase research supplies and/or technical
support for pilot projects in preparation for grant
applications. $5,000 was awarded to Joseph Isler, a
postdoctoral fellow with expertise in complex non-linear
systems and mathematical modeling allowing him to buy
equipment needed for his novel approach to analyzing
infant and fetal EEG responses. $2,000 was awarded to
Susan Brunelli for supplies and animal care costs to
study the role of a progesterone metabolite, allopregnanolone,
in an animal model of increased early separation anxiety.
$1,000 went to Harry Shair to ascertain the feasibility
of studying, in genetically altered mice, a novel potentiation
of infant separation responses previously discovered
in rats.
Part II - RESEARCH PROGRAMS
1. Basic Science Division
Dr. Thomas Jessell – Early Development
of the Vertebrate Nervous System
Our work has addressed the mechanisms
that control the assembly of neural circuits in the
vertebrate central nervous system. These studies have
explored the link between neuronal identity and circuitry:
how does the early specification of neuronal identity
define the position of neurons, the projection pattern
of their axons, and the selectivity of their synaptic
contacts? We have focused on neurons that form the monosynaptic
stretch reflex circuit in the spinal cord, for two reasons.
First, this circuit forms early in development, in an
activity-independent manner, suggesting that its assembly
is genetically encoded. Second, a century of anatomy
and physiology, from the pioneering studies of Sherrington
and Ramón y Cajal onward, has provided a rigorous cellular
and functional framework for interpreting molecular
steps in the assembly of sensory-motor connections.
Over the past year we have continued
our studies of the organization of motor neurons into
columns, a prominent feature of central nervous system
structure and function. In many regions of the central
nervous system the grouping of neurons into columns
links cell-body position to axonal trajectory, thus
contributing to the establishment of topographic neural
maps. This link is prominent in the developing spinal
cord, where columnar sets of motor neurons innervate
distinct targets in the periphery. We show here that
sequential phases of Hox-c protein expression and activity
control the columnar differentiation of spinal motor
neurons. Hox expression in neural progenitors is established
by graded fibroblast growth factor signalling and translated
into a distinct motor neuron Hox pattern. Motor neuron
columnar fate then emerges through cell autonomous repressor
and activator functions of Hox proteins. Our findings
reveal that Hox proteins also direct the expression
of genes that establish motor topographic projections,
thus implicating Hox proteins as critical determinants
of spinal motor neuron identity and organization.
In addition, we have been examining
the genetic control of locomotor behavior. The sequential
stepping of left and right limbs is a fundamental motor
behavior that underlies walking movements. This relatively
simple locomotor behavior is generated by the rhythmic
activity of motor neurons under the control of spinal
neural networks known as central pattern generators
(CPGs) that comprise multiple interneuron cell types.
Little, however, is known about the identity and contribution
of defined interneuronal populations to mammalian locomotor
behaviors. We have found that a discrete subset of commissural
spinal interneurons, whose fate is controlled by the
activity of the homeobox gene Dbx1, has a critical role
in controlling the left-right alternation of motor neurons
innervating hindlimb muscles. Dbx1 mutant mice lacking
these ventral interneurons exhibit an increased incidence
of cobursting between left and right flexor/extensor
motor neurons during drug-induced locomotion. Together,
these findings identify Dbx1-dependent interneurons
as key components of the spinal locomotor circuits that
control stepping movements in mammals.
Publications:
2003-2004 Sockanathan,
S., Perlmann, T. and Jessell, T.M. (2003). Contrasting
requirements for retinoid signaling in the specification
of motor neuron columnar identity at limb and thoracic
levels of the spinal cord. Neuron, 40 97-111.
Dasen, J.S., Liu, J-P., and Jessell,
T.M. (2003). Motor neuron columnar fate imposed by sequential
phases of Hox-c activity. Nature, 425 926-933.
Thaler, J.P., Lettieri, K., Andrews,
S., Cox, C., Jessell, T.M., and Pfaff, S.L. (2004).
A post-mitotic role for Isl-class LIM homeodomain proteins
in the assignment of visceral spinal motor neuron identity.
Neuron 41, 337-350.
Lanuza, G.M., Gosgnach, S., Pierani,
A., Jessell, T.M., and Goulding, M. (2004). Genetic
identification of spinal interneurons that coordinate
left-right locomotor activity. Neuron 42, 375-386.
Marklund, M., Sjödal, M., Beehler, B.C.,
Jessell, T.M., Edlund, T., and Gunhaga, L. (2004). Retinoic
acid signaling specifies intermediate character in the
developing telencephalon. Development, 131, 4323-4333.
Miles,G.B., Yohn , D.C. , Wichterle,
H., Jessell, T.M., Rafuse, V.F., and Brownstone, R.M.
(2004). Functional properties of motoneurons derived
from mouse embryonic stem cells. J. Neurosci. In Press.
Gu, C., Yoshida, Y., Livet, J., Reimert,
D.V., Mann, D., Merte, J., Henderson , C.E., Jessell,
T.M., Kolodkin, A.L., and Ginty, D.D. (2004). Semaphorin
3E and its receptor plexin-D1 control vascular patterning
independently of neuropilins. Submitted.
Gareth B. Miles, Damien C. Yohn, Hynek
Wichterle, Thomas M. Jessell, Victor F. Rafuse, and
Robert M. Brownstone. (2004). Functional Properties
of Motoneurons Derived from Mouse Embryonic Stem Cells.
J. Neurosci. 24, 7848-7858
Grant
Support Howard
Hughes Medical Institute 09/01/2002-08/31/2003
43%
Role: PI $613,992 (operating
expenses)
Molecular Analysis of Vertebrate
Neural Development
Research support from HHMI is currently
focused on experiments to examine the molecular basis
of synaptic specificity in the developing spinal cord,
with an emphasis on sensory-motor connections and role
role of local circuit interneurons in modifying motor
output.
R01 NS33245 09/01/1999
– 08/31/2005 10%
NIH $199,252
Role: PI
Control of Motor Neuron Differentiation
The aim of this grant since its inception
has been to define the cellular and molecular steps
that control motor neuron differentiation in the developing
spinal cord.
2P01 CA23767-25
NIH- National Cancer Institute
(Axel) 10/1/03 – 11/30/08 10%
Role: Project IV- Jessell
$129,655
Proto-oncogenes—Signaling in
Development and Neoplasia.
Project title: Cell Interactions in
Motor Neuron Differentiation. The main goal of this
proposal is to link the transcriptional regulation of
sensory neuron identity to key cell surface recognition
molecules that control axonal growth and target specificity
during the formation of the spinal sensory-motor reflex
circuit.
WELLT066790-C-02-Z
The Wellcome Trust 05/01/2002
04/30/2007 10%
Role: Project leader
on consortium grant. $293,732
Functional Genomics of Identified
Neurons
Project title: Functional genomics of
the motor neuron
The aim of this collaborative project
(with the Lumsden, DuLac, Kontges and Wernische labs)
is to use functional genomic methods to identify novel
genetic markers that permit the identification of motor
neuron subtypes.
Project ALS 1/21/2001
– 12/20/2004 5%
Role : PI $149,727
Regulated Gene Expression in
Motor Neurons and Neuron Progenitor Cells
The aim of this proposal is to apply
contemporary methods of gene manipulation in the mouse
to the study of the origins of ALS and to the design
of novel strategies to prevent the death of motor neurons
that occurs in ALS and other neurodegenerative disorder.
SCRIB51796001
NYS Spinal Injury Research Program
01/01/2004-12/31/2007 5%
Role: PI $100,000
Analysis of ES Cell Derived
Motor Neurons .
The aim of these studies is to optimize
procedures for introduction of ES cell derived spinal
cord neurons into adult spinal cord in normal and injured
states.
The G. Harold and Leila Y.
Mathers Charitable Foundation
9/1/2001-8/31/2007 5%
( PI: E. Kandel, M.D.) $175,000
Role : Project leader
Molecular Approaches to cognition:
The development and modification of internal representations
within the brain.
The overall aim of this project is to
determine how individual genes contribute to the cellular
properties essential for the development and maintenance
of cognitive maps. Studies in the Jessell project will
focus on the characterization of neuronal populations
that mediate sensory relay information in the dorsal
spinal cord.
CU51912001
Dana Foundation 10/01/2003
– 9/30/2006 2%
Role: PIs: Yong Ri
Zou and Jessell $50,000
The Functional and Signaling
Pathways of the Chemokine Receptor CXCR4 in the Immune
and the Central Nervous Systems
The primary goal of this proposed project
is to elucidate the conserved physiological function
of CXCR4 in the immune and nervous systems.
2. Behavioral Neuroscience Division
Dr. William Fifer - Human Fetal Behavior
and Intrauterine Influences on Vulnerability to Psychiatric
Illness
Our general research program focuses
on the effects of the early environment on fetal and
infant brain/behavior development. We continue to investigate
the effects of prenatal risk factors including maternal
nicotine and alcohol use during pregnancy, as well as
maternal stress and anxiety, on autonomic nervous system
development. With Dr. Monk, from the Department of Behavioral
Medicine, we continue our studies on the influence of
maternal depression and anxiety on fetal and infant
development. With Dr. Myers we continue to study early
markers of risk for Developmental Disorders and Sudden
Infant Death (SIDS) in high-risk populations in Washington
Heights and on the Pine Ridge Reservation in South Dakota
. A further extension of this work, with the Department
of Pediatrics, focuses on the developing nervous system
in prematurely born infants and, together with colleagues
from the Division of Environmental Health Science at
Columbia , assessments of sleep dependent physiology
in infants exposed to environmental toxins during pregnancy.
During this past fiscal year we have
received NIH funding for two additional projects. One
is to investigate sleep arousal mechanisms in at-risk
infants from a database collected as part of the NICHD
CHIME (Cooperative Home Infant Monitoring Evaluation
network). The second is a phase 1 planning grant as
part of an NIAAA/NICHD network to study the effects
of alcohol on SIDS, unexplained fetal demise and other
neurobehavioral disorders. This network focuses on high
risk populations in South Africa and the Dakotas .
Dr.
Myron Hofer - Process of Attachment and the Regulation
of Development
O ur research has centered on the role
of the parent-infant relationship as the first major
environmental influence on postnatal development. I
and my colleagues have explored how early maternal separation
and different patterns of mothering exert long-term
effects on vulnerability to disease. Through an experimental
analysis of the psychobiological events that enmesh
the infant rat and its mother, we are studying the hidden
regulatory processes that are the basis for the early
origins of attachment, the dynamics of the separation
response and the shaping of development by that first
relationship. Recent work with Drs. Brunelli and Shair
has focused on the infant rats' vocal response to isolation
as a model of the first anxiety state. We have explored
its neural basis, how it is regulated behaviorally by
littermates, dams and predators, and how its developmental
course can be altered by continued selection for high
and/or low responders.
In the last few years I have been interested
in what we can learn about development from the results
of targeted gene deletion in mice. For example, single
gene deletion can have very different effects when present
throughout development than when activated in adulthood.
In recent papers, Dr. Jay Gingrich's group in the Sackler
Laboratories and Sackler Awardee, Mark Ansorge, have
discovered paradoxical effects of serotonin transporter
inactivation in early development, unexpectedly increasing
adult depression-like behaviors. This has implications
for the treatment of depressed children, adolescents
and pregnant women with the widely used serotonin transporter
inhibitor drugs (SSRIs), as well as providing an experimental
model for the puzzling human finding of increased vulnerability
to depression in patients with abnormalities of the
serotonin transporter gene.
I am currently working on a book on
early development that I hope will help bridge the conceptual
gap that exists between Developmental Psychologists
and research at the cellular/molecular level in Developmental
Biology.
Dr.
Michael Myers - Early Nutritional Influences on Vulnerability
to Disease
Work in this laboratory continues
to be spurred by the renewed interest in the effects
of inadequate nutrition during pregnancy, undergrowth
of the fetus, and vulnerability to disease later in
life. From large scale epidemiological studies, it has
become clear the that cardiovascular disease, diabetes,
schizophrenia, and depression can all be influenced
by nutritional disturbances, as well as other types
of environmental stress during this critical period
of development. While long-term effects of early experiences
has been a focus of research within the field of Developmental
Psychobiology since its inception, the proximal mechanisms
and chain of events that account for enduring changes
in disease vulnerability remain largely undiscovered.
This is the ongoing focus of work in our group. In collaboration
with Drs. William Fifer and Harry Shair in our department,
and Drs. Morris Cohen and David Brown at Newark Beth
Israel Hospital , we continue to investigate these phenomena
in both animal models and human infants. NIH support
for these studies now totals over $500,000 per year.
Our studies focus on effects of variation
in nutrient availability in the perinatal period on
physiological, biochemical and behavioral characteristics
of newborn infants. Indices derived from animal studies
are incorporated into human studies, and the underpinnings
of correlative findings from human studies are pursued
in animal models. The studies will determine if human
infants with low birth weights, or rats whose mothers
were underfed during pregnancy, express differences
in cardiovascular and behavioral responses to feeding
and postural challenge. We are also pursuing gene expression
studies from placental tissue that will allow us to
determine with greater precision which infants experienced
suboptimal growth conditions during gestation. We are
also investigating the hypothesis that alterations in
methylation of regulatory regions of certain genes are
key to understanding the persistence of changes in gene
expression resulting from variation in nutrition early
in life.
Dr. Jonathan Polan –
I spent the academic year 2003-04
on sabbatical in the laboratory of Dr. Eric Kandel at
Columbia University 's Center for Neurobiology and Behavior
learning the concepts and techniques of molecular neurobiology
in order to apply them to research in developmental
psychobiology. In the Kandel lab I joined a group that
is creating genetically engineered mouse models of schizophrenia,
animals with selective dysfunctions of the dopamine
or glutamate systems limited to the striatum or neocortex,
the neurotransmitters and brain regions implicated in
schizophrenia. Because of strong evidence that schizophrenia
is a neurodevelopmental disorder, we focussed on the
developmental aspects of these animals' phenotypes using
a molecular switch to turn the transgenes off during
specific developmental windows. For the academic year
2004-05 this project is being funded by the Sackler
Research Award and by a grant from the Lieber Center
for Schizophrenia Research.
We turned off a transgene in a mouse
that over expresses the dopamine D2 receptor in the
striatum and causes a schizophrenia-like phenotype of
impaired working memory. We found that when the transgene
is inactivated in adulthood, the phenotype remains,
implying that the animal's cognitive impairment results
from overexpression of D2 receptors earlier in development.
After turning off the transgene throughout all of postnatal
life, our preliminary results are that the adult phenotype
still persists, suggesting that the excess doapminergic
function in the striatum exerts its pathologenic effect
on prenatal brain development. In addition,
we are beginning to apply stressors early in development
to these transgenic animals to model the "double hit"
hypothesis of schizophrenia, i.e., the hypothesis that
an interaction between both a genetic predisposition
and environmental stress is responsible for the full
syndrome.
Publications
Monk, C., Sloan, R.P., Myers, M.M.,
Ellman, L., Werner, E., Jeon, J., Tager, F., Fifer, W.P.
Fetal heart rate reactivity differs by women's psychiatric
status: an early marker for developmental risk? J Am Acad
Child Adolesc Psychiatry, 43:283-90, 2004. Myers MM,
Ali N, Weller A, Brunelli SA, Tu AY, Hofer MA, Shair HN.
Brief maternal interaction increases number, amplitude,
and bout size of isolation-induced ultrasonic vocalizations
in infant rats (Rattus norvegicus). J Comp Psychol, 118:95-102,
2004.
Monk, C., Myers, M.M., Sloan, R.P.,
Ellman, L. and Fifer, W.P. Effects of women's stress-elicited
physiological activity and chronic anxiety on fetal
heart rate. Journal of Development and Behavioral
Pediatrics , 24(1), 32-38, 2003.
Grieve, P.G., Emerson, R.G., Fifer,
W.P., Isler, J.R., and Stark, R.I. Spatial correlation
of the infant and adult electroencephalogram, Clinical
Neurophysiology 114(9),1594-608, 2003.
Fifer, W.P. and Moon, C.: Prenatal development.
In: A. Slater and G. Bremner (Eds.). An Introduction
to Developmental Psychology, Oxford , UK : Blackwell
Publishers Ltd., 95-114, 2003.
Weller, A., Leguisamo, A. C., Towns,
L., Ramboz, S., Bagiella, E., Hofer, M., Hen, R., &
Brunner, D. Maternal effects in infant and adult phenotypes
of 5HT1A and 5HT1B receptor knockout mice. Dev Psychobiol
42, 194-205, 2003
Hofer, M. A. The Emerging Neurobiology
of Attachment and Separation - How Parents Shape Their
Infant's Brain and Behavior. In S. W. Coates, Rosenthal,
J.L., Schechter, D.S., (Ed.), September 11 - Trauma
and Human Bonds (pp. 191-209). Hillsdale , NJ
: The Analytic Press 2003
Lira, A., Zhou M., Castanon N., Ansorge
M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira
J., Underwood M.D., Arango V., Kung H.F., Hofer M.A.,
Hen R., & Gingrich J.A. Altered depression- related
behaviors and functional changes in the dorsal raphe
nucleus of serotonin tansporter-deficient mice. Biol.
Psychiatry (10), 960-971, 2003
Hofer, M. A., Developmental Psychobiology
of Early Attachment. In B. J. Casey (Ed.), American
Psychiatric Publishing Review of Psychiatry Series
(Vol. 23): A.P.A Publishing Co. 2004
Sibolboro Mezzacappa E, Tu AY, Myers
MM. Lactation and weaning effects on physiological and
behavioral response to stressors. Physiology and Behavior,
78:1-9, 2003. McKinley PS, Shapiro PA, Bagiella E, Myers
MM, De Meersman RE, Grant I, Sloan
RP. Deriving Heart Period Variability From Blood Pressure
Waveforms. Journal of Applied Physiolog, in press, 2003.
Polan, HJ, Emergence of motivation in
the newborn's first relationship. Developmental
Psychobiology. In press
Grant Support (dollar figures are per
year)
“Perinatal Assessment of At-Risk Infants”
Principal Investigator: Fifer, William
P.
$398,920 (current year total)
Agency: NICHD Type: R01 (HD 32774) Period:
05/01/99 - 04/30/04
Goals: These studies focus on making
cardiorespiratory measurements in groups of human fetuses
and newborns who are at risk for developing subsequent
neurologic damage and/or Sudden Infant Death Syndrome.
“International Society for Developmental
Psychobiology Student Travel Grant”
Principal Investigator: Fifer, W.P.
$27,500.00
Agency: NIMH Type: R13MH (HD58769) Period:
10/01/00-9/30/05
“Environmental Health in a Cohort of
Minority Women/Infants”
Co-Investigator William Fifer
$826,189
Agency: NIEHS Type: R01 (ES08977) Period:
04/01/02-03/31/07
Goals: To investigate the impact of
pre- and post-natal exposures to air pollutants on fetal
growth and early childhood neurobehavioral development.
“Fetal Origins of Disease: Markers,
Modulators, Mechanisms”
Principal Investigator: Myers, Michael
M.
$312,612
Agency: NIEHS Type: R01 (ES11596) Period:
08/01/01 – 06/31/06
These are animal model and human infant
studies that focus on changes in cardiovascular function,
glucose regulation, and gene expression associated with
variations in early life growth and nutrition.
“Fetal Responses to Hypoxia and Nutrition
During Development”
Co-Director & Project IV: Michael
Myers
Co-Investigator: William Fifer
$636,715
Agency: NICHD Type: 3P01 (HD013063)
Period: 07/01/00 - 06/31/05
This program project conducts basic
physiologic and behavioral studies in human premature
infants, fetal baboons, and rodent models to investigate
responses to and detrimental effects of hypoxia, nutritional
variation and nicotine during the perinatal period.
“Hostility Reduction and Autonomic Control
of the Heart”
Co-Investigator Michael Myers
$321,058 (10%)
Agency: NHLBI Type: R01 (HL 63872) Period:
07/01/00 - 06/30/05
These studies investigate the effects
of cognitive behavioral therapy on psychophysiological
reactivity in subjects with high levels of hostility.
"Research Training in the Psychobiological
Sciences"
Principal Investigator: Hofer, Myron
A. Co-Director: Michael Myers
$250,066
Agency: NIMH Type: T32 (MH018264) Period:
07/01/03 - 06/30/08
Postdoctoral research training grant
for MD and PhDs in Psychobiology.
"Developmental Dopaminergic Excess,
Environmental Stress, and the Pathogenesis of Schizophrenia"
Lieber Center for Schizophrenia Research
Principal Investigator: Jonathan Polan
Amount: $80,000 per year
Duration: 7/1/04 -6/30/06
3. Clinical Research Division
Dr. Myrna Weissman - Clinical Epidemiology
Studies of Genetic Risk and Biological Markers in the
Development of Mood and Anxiety Disorders
Our overall goal has been to understand
the patterns, timing and risk for mood and anxiety disorders
across generations. We have followed and carefully clinically
characterized the samples of patients at risk for these
disorders and have followed them from childhood to adulthood.
More recently, we have used genetic, neuropsychological,
neurophysiologic and neuroimaging studies to better
understand the pathophysiology and neural circuitry
of these disorders.
The major work includes a three generation
study of offspring at high and low risk for depression.
The overall aim has been to better understand the long
term temporal sequence and familial patterns of psychiatric
disorders from childhood to adulthood, in offspring
at high and low risk for depression using clinical and
psychophysiological assessments, EEG and startle response.
The study has had four waves of assessments for over
20 years. A fifth wave is underway and three generations
have now been studied. The fourth wave of assessments
found high rates of psychiatric disorders, particularly
anxiety disorders in the grandchildren with two generations
of major depression. Fifty nine percent of these grandchildren
(mean age of 12) are already having psychiatric disorders.
The effects of the parental depression of the grandchild
outcomes differs significantly with grandparent depression
status. Among the grandchildren with a depressed grandparent
and parent there was over a five fold increase risk
of anxiety disorders and over a five fold risk of any
disorder. The pattern that we have observed in these
grandchildren (the third generation) paralleled what
we found in the parents (the second generation) when
they were followed from childhood to adulthood and in
the grandparents (the first generation) who retrospectively
reported their childhood conditions when we first surveyed
them as adult. The patterns in high risk children includes
an increase in anxiety disorders, mostly phobias, before
puberty with a marked rise in depression around puberty,
especially in females and a slight increase in substance
dependency in late adolescence and young adulthood.
The high rates and early onset of mood and anxiety disorders
on the grandchildren from two generations of depression
suggests that this group as contrasted with the low
risk group, could provide promising contrasts in neuroimaging,
genetic and other biological studies.
In collaboration with Dr. Bradley Peterson
we are now conducting functional and anatomical magnetic
imaging studies of these generations and are developing
hypothesis about brain endophenotypes using the EEG
and startle data. We have now completed about 115 MRIs
and this work will be progressing for the next two years.
We have also started to analyze the data from our EEG
and startle findings. The results of the EEG showed
that offspring with both parents having a major depression
had the greater alpha asymmetry at the medial sites
with relatively less activity over the right central
and parietal regions, when compared to the offspring
with having one or no parents with depression. Alpha
asymmetry is indicative of right parietotemporal hypoactivity,
previously reported for depressed adolescents and adults,
and heightened anterior to posterior gradient of alpha
are present in high risk offspring having parents concordant
for major depression.
The results of the startle response
found that startle discriminated between low and high
risk groups. In the probands' children, the high risk
group showed increased startle magnitude throughout
the fear-potentiated startle test. In the probands'
grandchildren, a gender-specific abnormality was found
in the high risk group, with high risk girls, but not
boys, exhibiting elevated startle magnitude throughout
the procedure. Increased startle reactivity in threatening
contexts, previously found in patients with anxiety
disorder and in children of parents with an anxiety
disorder, may constitute a vulnerability marker for
major depression. Both the EEG and the startle could
be endophenotypes.
We have been interested in the work
of Caspi et al who showed that functional polymorphism
in the promoter region of the serotonin transporter
gene moderated the effect of life events on developing
depression. Caspi's group showed that the effects of
the genes were conditional on exposure to an environmental
risk. Our findings suggest another point of heterogeneity
in depression. The development of depression in a young
person may be conditional on both the parent and grandparent
having a moderate to severe depression. These effects
may be independent of environmental confounders. Whether
these generations also carry the functional polymorphism
is an interesting unanswered question. We do have data
on life events and will be using some Sackler funds
to begin planning the collection of blood for DNA and
genetic analysis in the three generation study.
We have followed up previous findings
on the high familiality of recurrent major depression
beginning before the age of 30. As participants in a
multi-site study to identify major depression susceptibility
gene, the collection of about 1000 sib pairs with recurrent
early onset major depression has been completed. Biological
material and clinical data is being shared with the
scientific community. Data analyses of this study are
underway. Some of our findings on the potential differences
between prepubertal and adolescent onset depression
will be tested as potential different phenotypes.
Work is ongoing in a new initiative
to understand the genetic basis of fear and anxiety
disorders in humans by identifying variants forms of
genes that may contribute to pathological anxiety state.
The basic idea is that learned innate fear are tractable
target for genetic analysis in mice and humans; that
there are similarities in fear conditioning circuitry
between animal models and humans; that genes involved
in the pathway associated with fear in mice may be involve
in the development of human anxiety disorders. Candidate
genes that are identified from the study of learned
and innate fear will be tested in a sample of normal
humans with various degrees of fear conditioning, following
startle test. These genes may also be related to human
anxiety disorders. We are collecting samples of patients
with panic disorders, social anxiety disorders, and
normal controls. We are also characterizing these samples
on dimensions of anxious temperament for candidate gene
analyses. This work began this year and represents an
NIMH Program Project grant between Eric Kandel, Rene
Hen, Conrad Gilliam, Abby Fyer, and Myrna Weissman.
We have used the Sackler funds to encourage
young investigators to further develop the data from
our clinical sample. Adriana Feder, MD is studying twenty-four-hour
cortisol secretion patterns in prepubertal children
with depression, anxiety and normal controls in a longitudinal
clinical follow up into young adulthood. Her study yielded
the largest sample of 24-hour cortisol and growth hormone
data in prepubertal children with depression and anxiety
(n=124). She has reanalyzed biological data collected
in children in light of longitudinal clinical follow-up
of subjects as young adults. Preliminary findings indicate
that prepubertal children with major depression, as
well as children who are at risk for developing major
depression by young adulthood, show abnormalities in
their 24-hour cycle of cortisol secretion. In particular,
they appear to exhibit a phase delay in the rise of
cortisol in the early morning hours. This is a normally
cortisol-active period preceding awakening. This neuroendocrine
abnormality may represent a trait marker for MDD, in
this population, thus a potential way of identifying
prepubertal children with MDD, or at risk for MDD, in
the future. Her findings, if confirmed, may pave the
way for developing prevention and early intervention
strategies for this population.
Sanjay Mathew , MD partially funded
by Sackler has just completed MRS examination study
on sample of adolescent onset depressives followed into
adulthood and compared to controls. Data are being analyzed.
Two new collaborations were initiated
this year between our group and other members of the
Sackler Institute. Yoko Nomura, Ph.D. following up some
our efforts to identify multitude risk factors for early
onset depression working with William P. Fifer, Ph.D.
received an NIMH grant to study pathways to psychiatric
and medical comorbidity. Exposure to perinatal problems
and social adversity in conjunction with maternal depression
may explain the increased risk of behavioral, emotional,
and medical problems in offspring in their infancy,
childhood, and adulthood. Individuals with psychiatric
illness such as depression who have a comorbid medical
problem have increased functional impairment, more frequent
use of health care services, and a higher prevalence
of suicidal ideation. Elucidation of the mechanism through
which the phenomenon occurs, through examination of
problems across the life cycle (birth, infancy, childhood,
and adulthood), will help clarify the temporal sequences
of the selected comorbid medical illness (allergies,
headaches, and heart disease). Exploiting an unparalleled
opportunity to utilize the dataset from a community-based
longitudinal study (N=1758) that followed parents and
their offspring for over 30 years, the proposed study
has 5 aims: 1) to investigate direct and indirect (through
social adversity) effects of perinatal risk on different
problems (emotional/behavioral, medical, and neurological)
in infancy and childhood, as well as psychiatric and
medical illness in adulthood; 2) elucidate pathways
from social adversity and perinatal risk to adult psychiatric
and medical illness, mediated through different problems
in infancy and childhood; 3) to examine the temporal
sequence of psychiatric and medical illness, from childhood
to adulthood; 4) to compare the level of social and
functional impairment, such as suicidal ideation, hospital
use, and personal resources among those with both psychiatric
and comorbid medical illness, those with one and neither
illness; 5) to examine the role of maternal depression
and family support as moderators.
Catherine Monk, Ph.D. a former fellow
of the Sackler Institute and a member of Dr. Hofer's
group was assisted by Weissman in successfully preparing
an NIMH grant on interpersonal psychotherapy for depressed
pregnant mothers, to follow the mothers through pregnancy
and post partum and to study their infants.
Publications
Blanco C, Clougherty KF, Lipsitz KF,
Mufson L, Weissman MM. Interpersonal Psychotherapy.
In Gabbard G, Beck J, Holmes J (eds.) Journal of
Psychotherapy Integration (Special Series): Integrating
between-session homework activities into different psychotherapies.
Concise Oxford Textbook of Psychotherapy. Gabbard, GO,
Beck J, Holmes JA. In press, 2003.
Charney DS, Reynolds III CF, Lewis L;
Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG,
Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce
ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN,
Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden
SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin
DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds
M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unützer
J, Weissman MM, Young RC. Depression and bipolar support
alliance consensus statement on the unmet needs in diagnosis
and treatment of mood disorders in late life. Arch
Gen Psychiatry 60:664-672, 2003.
Feder A, Goetz RR, Coplan JD, Mathew
SJ, Pine DS, Greenwald S, Dahl RE, Ryan ND, Weissman
MM. Twenty-four hour cortisol secretion patterns in
prepubertal children with anxiety or depressive disorders.
Biol Psychiatry 56:198-204, 2004.
Goodwin R, Olfson M, Shea S, Lantigua
RA, Carrasquillo O, Gameroff MJ, Weissman MM. Asthma
and mental disorders in primary care. Gen Hosp Psychiatry
25(6):479-83, 2003.
Hamilton SP, Slager SL, Baisre de Leon
A, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer
AJ, Knowles JA. Evidence for genetic linkage between
a polymorphism in the Adenosine 2A receptor (ADORA2A)
and panic disorder. Neuropsychopharmacology 29:558-565,
2004.
Hamilton SP, Slager SL, Mayo D, Heiman
GA, Klein DF, Hodge SE, Fyer AJ, Weissman MM, Knowles
JA. Investigation of polymorphisms in the CREM gene
in panic disorder. Am J Med Genet
126B: 111-115, 2004.
Hirschfeld RMA, Calabrese JR, Weissman
MM, Reed M, Davies MA, Frye MA, Keck PE , Lewis L, McElroy
SL, McNulty J, Wagner KD, Holzer C. Using questionnaires
to screen for psychiatric disorders: A comment on a
study of screening for bipolar disorder in the community.
J Clin Psychiatry 65(5): 721-722, 2004.
Holmans P, Zubenko GS, Crowe RR, DePaulo
JR, Scheftner WA, Weissman MM, Zubenko WN, Boutelle
S, Murphy-Eberenz K, Mackinnon D, McInnis MG, Marta
DH, Adams P, Knowles JA, Gladis M, Thomas J, Chellis
J, Miller E, Levinson DF. Genomewide significant linkage
to recurrent, early-onset major depressive disorder
on chromosome 15q. Am J Hum Genet 74: 1154-1167,
2004.
Judd F, Weissman MM, Davis J, Hodgins
G, Piterman L. Interpersonal counseling in general practice.
Aust Fam Physician 33(5): 332-337, 2004.
Mathew SJ, Coplan JD, Goetz RR, Feder
A, Greenwald S, Dahl RE, Ryan ND, Mann JJ, Weissman
MM. Differentiating depressed adolescent twenty-four
hour cortisol secretion in light of their adult clinical
outcome. Neuropsychopharmacology 1336-1343,
2003 .
Mufson L, Pollack-Dorta KE, Moreau D,
Weissman MM. Efficacy to effectiveness: Adaptations
of interpersonal psychotherapy for adolescent depression.
(Chapter) in Hibbs ED, Jensen PS (eds) Psychosocial
Treatments for Child and Adolescent Disorders: Empirically-based
Strategies for Clinical Practice, 2 nd edition.
American Psychological Association. In press, 2003.
Mufson L, Pollack Dorta K, Moreau D,
Weissman, MM. Interpersonal Psychotherapy for Depressed
Adolescents, 2 nd edition. Guilford Publications, Inc.,
New York , 2004.
Mufson L, Pollack-Dorta KE, Wickramaratne
PJ, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness
trial of interpersonal psychotherapy for depressed adolescents.
Arch Gen Psychiatry 61:577-584, 2004.
Olfson M, Tobin JN, Cassells A, Weissman
MM. Improving the detection of drug abuse, alcohol abuse
and depression in community health centers. J Health
Care Poor Underserved 14(3):386-402, 2003.
Oquendo MA, Lizardi D, Greenwald S,
Weissman MM, Mann JJ. Rates of lifetime suicide attempt
relative to rates of lifetime major depression in different
ethnic groups in the United States . Acta Psychiatr
Scand In press, 2004.
Pilowsky DJ, Birmaher B, Weissman MM.
Approaches to chronic depression in children and adolescents.
In Alpert J, Fava M (eds) Handbook of Chronic Depression.
Marcel Dekker, Inc. NY, 2004, pp. 339-362.
Verdeli H, Ferro T, Wickaramaratne P.,
Greenwald S, Blanco C, Weissman MM. Treatment of depressed
mothers of depressed children: Pilot study of feasibility.
Depression & Anxiety , 19(1):51-59, 2004.
Weissman MM. The epidemiology of bipolar
disorder. In Goodwin F, Jamison K (eds.), Manic
Depressive Illness, Oxford University Press, In
press, 2003.
Weissman MM. Phobias in primary care
and in young children. (Commentary) In Maj M, Akiskal
HS, López-Ibor JJ, Okasha A (eds). WPA Series, Evidence
and Experience in Psychiatry. John Wiley & Sons
Ltd, 2004, pp. 342-344.
Weissman MM, Warner V, Wickramaratne
PJ, Nomura Y, Merikangas KR, Bruder GE, Tenke CE, Grillon
C. Offspring at high and low risk for depression: Preliminary
findings from a three generation study. In Gorman JM
(ed) Fear and Anxiety: The Benefits of Translational
Research . American Psychiatric Publishing, Inc.,
NY 2004, pp. 65-83.
Weissman MM. Epidemiologic Phenotype
Hunting: Panic Disorder and Interstitial Cystitis. In
Eaton W (ed) Medical and Psychiatric Comorbidity over
the Course of Life, APPI, Washington DC, In press 2004.
Weissman MM, Feder AJ, Pilowsky D, Olfson
M, Fuentes M, Blanco C, Lantigua R, Gameroff MJ, Shea
S. Depressed mothers coming to primary care: Maternal
reports of problems with their children. J Affective
Dis 78:93-100, 2004.
Weissman MM , Gross R , Fyer AJ, Heiman
GA, Gameroff MJ, Hodge SE, Kaufman D, Kaplan SA, Wickramaratne
PJ. Interstitial cystitis and panic disorder: A potential
genetic syndrome. Arch Gen Psychiatry 6.1:273-279,
2004.
Weissman MM, Wickaramartne PJ, Nomura
Y, Warner V, Verdeli H, Pilowsky DJ, Grillon C, Bruder
G. Families at high and low risk for depression: A three
generation study. Arch Gen Psychiatry, In
press, 2004.
Wilson JJ, Pine DS, Cargan A, Goldstein
RB, Nunes EV, Weissman MM. Neurological soft signs and
disruptive behavior among children of opiate dependent
parents. Child Psychiat Hum Dev 34(1): 19-34,
2003.
Wilson JJ, Nunes EV, Greenwald S, Weissman
MM. Verbal deficits and disruptive behavior disorders
among children of opiate dependent parents. Am J
Addict 13:202-22, 2004.
Grant Support (dollar figures are per
year)
Myrna M. Weissman, Ph.D.
5 RO1 MH60912-04 (Weissman) 09/30/99
- 08/31/04 5% effort
NIH/NIMH $247,683 (No cost extension)
Genetics of Early-Onset Major Depression
A six-site cooperative project to collect
a large sample of subjects with early-onset MDD obtaining
clinical data and genetic samples aiming to map genes
giving a susceptibility to MDD.
2 RO1 MH28274-26 (Weissman) 07/08/02
to 06/30/05 10% effort
NIH/NIMH $265,160 (No cost extension)
Genetic Studies of Depressive Disorders
This is a project to understand the
etiology of panic disorder using a broad range of novel
and advanced genetic and epidemiologic approaches.
5 R01 MH63852-04 (Weissman) 07/19/01
to 06/30/06 20% effort
NIMH $776,539
Children of Depressed Mothers: a STAR*D
Ancillary Study
The overall aim is to study the impact
of a reduction of maternal depressive symptoms on children
= s psychiatric symptoms and social functioning as an
ancillary study to the Sequenced Treatment Alternatives
to Relieve Depression study (STAR*D).
2 T32 MH16434-21 (Shaffer) 07/01/00
to 06/30/05 <1% effort
NIH/NIMH $488,000
Research Training in Child Psychiatry
The Child Psychiatry Research Training
Program trains postdoctoral psychiatrists, psychologists,
and others to become independent investigators in the
field of child and adolescent psychopathology. The grant
supports ten M.D. and/or Ph.D. trainees for up to three
years.
5 P30 MH60570-05 (Shaffer) 09/24/99
to 05/31/05 <1% effort
NIH/NIMH $129,307 (Core Only) (No Cost
extension)
Psychotherapy Core, part of Child Psychiatry
Intervention Research Center
Provide consultation to investigators
on the technology of psychotherapy research and its
testing by facilitating training in empirically based
treatments and identifying opportunities to test out
psychotherapies, both in terms of adapting existing
therapies to new uses and implementing new therapies.
5 R01 MH 36197-20 (Weissman) 01/01/03
- 12/31/08 25% effort
NIH/NIMH $620,928
Children at High and at Low Risk for
Depression
Overall aim of this study is to understand
the long term temporal sequence and familial patters
of mood and other disorders from childhood to adulthood
in offspring at high and low risk for depression. The
study now includes three generations. The aims during
this project period are (1) to complete data analyses
of the 4 th wave of assessments; (2) acquire and analyze
both anatomical and functional MRI in 214 subjects;
(3) conduct data analyses integrating clinical, psychophysiological,
and neuroimaging studies.
1 P01 MH60970-02(Gilliam) 12/1/02-11/30/06
15% effort
NIH/NIMH $237,374 (Project 4 only)
Molecular Genetic Studies of Fear and
Anxiety (Weissman is Director of Project 4 “ Clinical
Studies of Human Anxiety
This is a program project to study the
molecular and genetic basis of amygdala-regulated fear
and anxiety in mice and humans. Several fear conditioning
paradigms will be studied in both mice and humans, along
with selected anxiety related traits and disorders in
humans. Genes that alter fear-conditioning phenotypes
in mice will be analyzed for trait-related DNA sequence
variation in humans who score at the phenotypic extremes
for the matched paradigm. Genes shown to alter other
anxiety measurements in mice will be analyzed for trait
or disorder-related variation in humans with a variety
of anxiety-related temperaments and disorders.
1 P60 MD000206-02(Carrasquillo) 10/01/02-9/30/07
8% effort
NIH/NCMHHD $75,651 Core Only
Columbia Center for the Health of Urban
Minorities - Core 7 (Olfson)
The overall aim of the Mental Health
Research Core is to facilitate the development and research
evaluation of mental health interventions for low income
minority populations
Josiah P Macy Foundation 07/01/03-06/30/05
5% effort
$100,000
Bridging the Gap Between Research and
Clinical Practice in Modern Psychotherapy
The overall goal is to decrease the
considerable gap that now exists between the availability
of evidence based treatments (EBT), particularly psychotherapy,
and training of clinical practitioners, in psychiatry,
psychology, and social work, who actually provide psychotherapy
to the patients.
4. Developmental Neuro-imaging
Laboratories
Dr. Bradley Peterson – Normal Brain
Development and the Neural Basis of Psychiatric Disorders
MRI
Unit
The MRI Unit that Dr. Peterson directs
opened for research studies in February of this year.
It is a 3.0 Tesla scanner manufactured by GE. Equipped
recently with the new “parallel imaging” capabilities,
it is one of the best performing research scanners in
the world. Please see the accompanying brochure, sent
to all departmental faculty, describing some of the
services provided by the Unit, along with our intensive
efforts to help new investigators apply MRI methodologies
within their ongoing research projects.
Funded
Projects
Major activities in Dr. Peterson's pediatric
imaging laboratory have focused on securing adequate
funding for staff and ongoing projects. Two large independent
investigator awards (R01's) were received from the NIMH,
and a midlevel Career Development Award for Dr. Peterson
was submitted. One funded R01 will study 135 newborn
infants with MRI to assess brain structure, connectivity,
and metabolites in 45 infants exposed prenatally to
crack cocaine, 45 to narcotics, and 45 who were never
exposed.
The other funded R01 provides support
for morphometric analyses of 620 MRI scans previously
obtained in children and adults who have Tourette syndrome,
OCD, or ADHD, or who are healthy comparison subjects.
Brain-based correlates of morphological measures with
performance on cognitive tasks, with brain activity
on fMRI scans, and genetic variation will be assessed.
Collaboration with Drs. Myrna Weissman
of the Sackler Institute has continued in our third
funded R01, and we have thus far successfully scanned
125 individuals in a large, 3-generational cohort that
has been followed by Dr. Weissman over the past 20 years.
Individuals in all 3 generations who are at either high
or low risk for major depressive illness are being studied
with MRI and with neuropsychological tasks designed
to test the integrity of neural systems thought to be
dysfunctional in depression.
Finally, in collaboration with Dr. Christina
Hoven and colleagues in the School of Public Health
, we have received funding to study the effects of trauma
on the CNS in children and their parents who resided
in close proximity to the World Trade Center on 9/11/01.
We will be scanning 80 representative children and their
parents who were evacuated from the site after the disaster,
as well as 80 matched control children and their parents
who were not in physical proximity to the trauma.
Publications
Chae J-H, Jeong J, Peterson BS, Kim
D-J, Bahk W-M, Jun T, Kim S-Y, Kim K-S . Dimensional
complexity of the EEG in patients with Post-Traumatic
Stress Disorder . Psychiatry Res:Neuroimaging ,
131(1):79-89, 2004 .
Spessot AL, Plessen KJ, Peterson BS.
Neuroimaging of developmental psychopathologies: The
importance of self-regulatory and neuroplastic processes
in adolescence. Ann NY Acad Sci ,1021:86-104,
2004.
Alexander GM, Peterson BS. Testing the
prenatal hormone hypothesis of tic-related disorders:
gender identity & gender role behavior. Develop
Psychopath , 16, 407-420, 2004 .
von Plessen K, Wentzel-Larsen T, Hugdahl
K, Feineigle P, Klein J, Staib L, Leckman JF, Bansal
R, Peterson BS. Altered interhemispheric connectivity
in individuals with Tourette syndrome. Am J Psychiatry
, in press.
Marsh R, Alexander GM, Packard MG, Zhu
H, Wingard JC, Quackenbush G, Peterson BS. Habit learning
in children and adults with Tourette Syndrome: A translational
neuroscience approach to a developmental psychopathology.
Arch Gen Psychiatry , in press.
Xu D, Mori S, Shen D, Peterson BS, Davatzikos
C. Warping diffusion tensor images. IEEE Trans Medical
Imaging , in press.
Bansal R Staib LH, Whiteman R, Wang
YM, Peterson BS. ROC-based assessments of 3D cortical
surface-matching algorithms. Neuroimage , in
press.
Posner J, Russell J, Peterson BS. The
circumplex model of affect: an integrative approach
to affective neuroscience, cognitive development, and
psychopathology. Develop Psychopath , in press.
Kim D-J, Yoon S-J, Choi B, Kim T-S,
SupWoo Y, Kim W, Myrick H , Peterson BS, Jeong J. Increased
fasting plasma ghrelin levels during alcohol abstinence.
Alcohol and Alcoholism , in press.
Peterson BS, Panksepp J. The biological
basis of childhood neuropsychiatric disorders. In: Panksepp
J (Ed.). A Textbook of Biological Psychiatry .
New York : John Wiley & Sons, Inc. 2003, pp.393-436
Spessot AL, Peterson BS. Tourette Syndrome:
A Multifactorial, Developmental Pychopathology. In press
in: Dante Cicchetti & Donald J. Cohen (Eds.) Manual
of Developmental Psychopathology . 2 nd edition.
New York : John Wiley
Blumberg HP, Kaufman J, Martin A, Charney
DS, Krystal JH, Peterson BS S ignificance of adolescent
neurodevelopment for the neural circuitry of bipolar
disorder. Ann NY Acad Sci, 1021:376-383, 2004
.
Grant Support
• National Alliance for Research on
Schizophrenia and Depression (NARSAD) Independent Investigator
Award. MRI in unaffected children at high and low risk
for depression (B. Peterson, PI) To identify the neural
correlates of trait familial vulnerabilities to major
depression in a sample of children who are unaffected
by the illness but who are at high risk for developing
it. (5% effort)
9/15/02-9/14/04
Annual Direct Cost $46,296 Total Direct
Cost $92,592 Total Cost $100,000
2002 NIMH Children at High and Low Risk
for Depression, MH36197 (M. Weissman. & B Peterson,
Co-PI's)
20% Effort. To identify the brain-based
correlates of children and adults at high or low risk
for depressive illness using anatomical and functional
MRI.
1/1/03-12/31/08
Initial Annual Cost $635,513 Total Direct
Cost $3,258,079
$4,593,000
2004 NIDA MRI of Infants Exposed Prenatally
to Drugs of Abuse, DA017820 (B. Peterson, PI)
25% Effort. To define the effects of
drugs of abuse on brain structure and metabolite concentrations,
as well as the behavioral correlates of those effects,
in infants and children who have been exposed to drugs
of abuse during fetal development.
4/01/04-3/31/09
Annual Direct Cost $499,938 Total Direct
Cost $2,497,828
$3,636,292
2004 NIMH Neuroanatomical MRI Studies
of Childhood Disorder, MH068318 (B. Peterson, PI)
30% Effort. To understand normal brain
development and the neural basis of childhood neuropsychiatric
disorders using anatomical MRI.
7/01/04-6/30/09
Annual Direct Cost $499,999 Total Direct
Cost $2,499,995
$4,000,427
2004 NIMH WTC Impact, Familial Transmission
and Child PTSD, MH070424 (C. Hoven, PI)
We will use MRI to study the effects
of trauma on the CNS in children and their parents who
resided in close proximity to the World Trade Center
on 9/11/01. We will be scanning 80 representative children
and their parents who were evacuated from the site after
the disaster, as well as 80 matched control children
and their parents who were not in physical proximity
to the trauma.
Role: Director of the MRI research component
of the project.
4/04/04-4/03/05
Annual Direct Cost $426,563 Total Direct
Cost $426,563
$ 601,611
5. Sackler Awardee
Dr. Cheryl Corcoran
The funding that I received from the
Sackler Institute was for a study of stress and symptoms
in adolescents and young adults who have enhanced clinical
risk for psychosis and schizophrenia. In the first year
of the grant, preliminary analysis was done of cross-sectional
data collected in collaboration with Barbara Cornblatt
at her RAP prodromal research clinic. These data showed
that emerging positive symptoms were related in prodromal
patients to both life event exposure and to cortisol
secretion in response to a laboratory stressor. Of note,
prodromal patients were not found to have an excess
of life events as compared with normal controls, which
suggests that the symptoms were not causing the life
events. Further, HPA activity in response to a stressor
was correlated with endorsement by patients of “impaired
tolerance to normal stress”, which characterized nearly
half of all prodromal patients and none of the controls.
These pilot data supported the rationale
for a longitudinal study of stress and symptoms in a
prodromal sample, with the aim of testing the stress-diathesis
hypothesis of psychosis onset in schizophrenia. These
data analyses were therefore crucial to obtaining funding
as from NIMH for a K23 award, entitled “Schizophrenia
risk to onset: Neurobiology and prevention”, which began
in April of 2004. It entails a prospective cohort study
of prodromal patients that employs clinical methodologies
that probe HPA axis function, prodromal symptoms and
psychosocial stress exposure. The main hypothesis is
that baseline stress-reactivity (stress reactive cortisol
and impaired tolerance to normal stress) and intervening
life events will increase risk for psychosis in prodromal
patients. The training plan for this K23 award involves
increased expertise in 1) prodromal research and neuropsychology;
2) adolescent cognitive and social development; 3) data
analysis in longitudinal studies and 4) assessment of
stress and the HPA axis in schizophrenia.
More generally, the Sackler Award was
also instrumental simply in launching a prodromal research
clinic here at NYSPI and Columbia , the Center of Prevention
and Evaluation (COPE). Since the last report, in the
past year, the COPE clinic has recruited an additional
18 patients who are all actively engaged in the protocol.
Recruitment is ongoing, with distribution of brochures,
liaison with schools, and contact with potential referrals,
both here at Columbia/NYSPI and in the community.
Therefore, in addition to providing
data for examination of the stress-vulnerability hypothesis
of schizophrenia, the COPE prodromal research clinic
is now the site for collaborative pilot studies that
evaluate other aspects of risk and pathophysiology,
including electrophysiology (Bruder and Foxe), structural
and functional imaging (Small), cannabis exposure (Kleber),
and family and social factors (Thorning). Each of these
pilot studies are being done with the expectation of
generating preliminary data for R01 applications.
Further, COPE has also become a vital
resource for other young investigators who are interested
in early schizophrenia and the unfolding of pathophysiological
processes, including two schizophrenia research fellows
(neuropsychology), two adult psychiatry residents (phenomenology
and imaging), a child psychiatry resident (social functioning
during the prodrome). There is now also a collaboration
with basic scientists, specifically Holly Moore and
her fellows, to study the prodrome in an animal model
of schizophrenia.
In sum, the Sackler Award has been absolutely
instrumental in providing bridge funds for me as an
investigator between my research fellowship and initiation
of a K23 award in the spring of 2004. The Sackler funding
enabled me to collect pilot data that were instrumental
in receiving a training award. Further, I believe the
generosity of the Sacklers has led to the launching
of a research clinic that is a tremendous resource now
for other young investigators and which is the site
for the initiation of several important collaborations
that will shed light on the development of schizophrenia,
in the trajectory from latent to manifest illness. I
am immensely grateful for the opportunity afforded to
me by the Sackler Award to initiate research in such
an exciting area and to work toward becoming an independent
investigator with expertise in prodromal research, uniquely
regarding potential triggers and intervening variables
in psychosis risk.
PUBLISHED ARTICLES (2003)
• * Corcoran C, Walker
E, Huot R, Mittal V, Tessner K, Kestler L: The Stress
Cascade and Schizophrenia: Etiology and Onset. Schizophrenia
Bulletin. 2003. Vol. 29 (4): 671- 692.
• * Corcoran C , Davidson
L, Sills-Shahar R, Nickou C, Malaspina D, Miller T,
McGlashan T: A Qualitative Research Study of the Evolution
of Symptoms in Individuals Identified as Prodromal to
Psychosis. Psychiatric Quarterly. 2003 Winter;74(4):313-32.
ARTICLES IN PRESS (2004)
• Corcoran C, Malaspina
D, Herscher L: Prodromal Interventions for Schizophrenia
Vulnerability: the Risks of Being “At Risk”, Schizophrenia
Research.
ARTICLES IN SUBMISSION (2004)
(1) * Corcoran C ,
Coleman E, Seckinger RA, Whitaker A, Fried J, Malaspina
D: Olfactory Deficits in Childhood Psychoses and their
Associations with Symptoms and Cognition. Submitted
to Biological Psychiatry
BOOK CHAPTERS (2004)
• Stanford AD, Corcoran C ,
Malaspina D (in press). Schizophrenia, In:
Merritt's Neurology, ed. Rowland, LP. Lippincott, Williams
& Wilkins,
Philadelphia , PA.
• Malaspina D , Corcoran C
, Goudsmit N (in press). Role of Olfaction
in Social Function, In: Olfaction and the Brain: Window
to the Mind, ed. Brewer W, Castle D, Pantelis C. Cambridge
University Press.
Part III Financial Report
3/12/2005
SklrAnnualRpt.2004
|